U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285226) titled 'Creatine HCl Supplementation in Sarcopenia: A Randomized Controlled Study' on Dec. 03.
Brief Summary: The CONCRET-SARCOPA trial is a 12-week, double-blind, randomized controlled study designed to evaluate the efficacy of creatine HCl supplementation in older adults with sarcopenia. The trial investigates whether daily creatine HCl improves body composition, enhances functional muscle and cognitive performance, and favorably alters key blood biomarkers associated with muscle health and metabolic status. Additionally, the study assesses changes in tissue creatine levels using non-invasive and biochemical methods to clarify mechanistic...